The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity

Abstract Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alan K. Okada, Kazuki Teranishi, Fleur Lobo, J. Mario Isas, Jialin Xiao, Kelvin Yen, Pinchas Cohen, Ralf Langen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0f99bdda07fa499097deb4fdc1230f9a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f99bdda07fa499097deb4fdc1230f9a
record_format dspace
spelling oai:doaj.org-article:0f99bdda07fa499097deb4fdc1230f9a2021-12-02T11:40:42ZThe Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity10.1038/s41598-017-08372-52045-2322https://doaj.org/article/0f99bdda07fa499097deb4fdc1230f9a2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08372-5https://doaj.org/toc/2045-2322Abstract Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate the cell’s unfolded protein response via direct interactions with amyloidogenic proteins. Here, we explored the effects of the MDP-analog, humaninS14G (HNG), and the MDP, small humanin-like peptide 2 (SHLP2), on the misfolding of islet amyloid polypeptide (IAPP), a critical pathogenic step in type 2 diabetes mellitus (T2DM). Our thioflavin T fluorescence studies show that HNG inhibits IAPP misfolding at highly substoichiometric concentrations. Seeded fluorescence and co-sedimentation studies demonstrate MDPs block amyloid seeding and directly bind misfolded, seeding-capable IAPP species. Furthermore, our electron paramagnetic resonance spectroscopy and circular dichroism data indicate MDPs do not act by binding IAPP monomers. Taken together our results reveal a novel chaperone-like activity wherein these MDPs specifically target misfolded amyloid seeds to inhibit IAPP misfolding which, along with direct anti-apoptotic activity and beneficial metabolic effects, make HNG and SHLP2 exciting prospects as T2DM therapeutics. These data also suggest that other mitochondrial stress response factors within the MDP family may be amenable to development into therapeutics for protein-misfolding diseases.Alan K. OkadaKazuki TeranishiFleur LoboJ. Mario IsasJialin XiaoKelvin YenPinchas CohenRalf LangenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alan K. Okada
Kazuki Teranishi
Fleur Lobo
J. Mario Isas
Jialin Xiao
Kelvin Yen
Pinchas Cohen
Ralf Langen
The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
description Abstract Mitochondrial-derived peptides (MDPs) and their analogs have emerged as wide-spectrum, stress response factors protective in amyloid disease models. MDP cytoprotective functions are generally attributed to anti-apoptotic activity, however, little is known about their capacity to facilitate the cell’s unfolded protein response via direct interactions with amyloidogenic proteins. Here, we explored the effects of the MDP-analog, humaninS14G (HNG), and the MDP, small humanin-like peptide 2 (SHLP2), on the misfolding of islet amyloid polypeptide (IAPP), a critical pathogenic step in type 2 diabetes mellitus (T2DM). Our thioflavin T fluorescence studies show that HNG inhibits IAPP misfolding at highly substoichiometric concentrations. Seeded fluorescence and co-sedimentation studies demonstrate MDPs block amyloid seeding and directly bind misfolded, seeding-capable IAPP species. Furthermore, our electron paramagnetic resonance spectroscopy and circular dichroism data indicate MDPs do not act by binding IAPP monomers. Taken together our results reveal a novel chaperone-like activity wherein these MDPs specifically target misfolded amyloid seeds to inhibit IAPP misfolding which, along with direct anti-apoptotic activity and beneficial metabolic effects, make HNG and SHLP2 exciting prospects as T2DM therapeutics. These data also suggest that other mitochondrial stress response factors within the MDP family may be amenable to development into therapeutics for protein-misfolding diseases.
format article
author Alan K. Okada
Kazuki Teranishi
Fleur Lobo
J. Mario Isas
Jialin Xiao
Kelvin Yen
Pinchas Cohen
Ralf Langen
author_facet Alan K. Okada
Kazuki Teranishi
Fleur Lobo
J. Mario Isas
Jialin Xiao
Kelvin Yen
Pinchas Cohen
Ralf Langen
author_sort Alan K. Okada
title The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
title_short The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
title_full The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
title_fullStr The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
title_full_unstemmed The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity
title_sort mitochondrial-derived peptides, humanins14g and small humanin-like peptide 2, exhibit chaperone-like activity
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/0f99bdda07fa499097deb4fdc1230f9a
work_keys_str_mv AT alankokada themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT kazukiteranishi themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT fleurlobo themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT jmarioisas themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT jialinxiao themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT kelvinyen themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT pinchascohen themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT ralflangen themitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT alankokada mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT kazukiteranishi mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT fleurlobo mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT jmarioisas mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT jialinxiao mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT kelvinyen mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT pinchascohen mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
AT ralflangen mitochondrialderivedpeptideshumanins14gandsmallhumaninlikepeptide2exhibitchaperonelikeactivity
_version_ 1718395562803331072